Dr. Aaron Gazendam
MD, MSc, FRCSCOrthopaedic Surgeon
Phone
(416) 596-4200 x4945
Fax
(416) 231 2432
Affiliated Hospital(s)
Mount Sinai Hospital, Princess Margaret Hospital (UHN)
Practice Location
600 University Avenue
Suite 476D
Assistant
Sarah Myke
Biography
Education
2010-2014 – Bachelor of Science, Queen’s University
2014-2018 – Doctor of Medicine, University of Toronto
2021-2022 – Master of Science, McMaster University
2018-2023 – Orthopaedic Surgery Residency, McMaster University
2023-20234- Clinical Fellow, Musculoskeletal Oncology, University of Toronto
Dr. Gazendam completed his medical degree at the University of Toronto before pursuing his orthopaedic surgery residency and a Master of Science in Health Research Methodology at McMaster University. He then returned to Toronto for fellowship training in orthopaedic oncology at Mount Sinai Hospital and the University of Toronto.
Dr. Gazendam’s clinical practice is dedicated to the surgical management of bone and soft-tissue sarcomas and metastatic bone disease. He has expertise in complex limb-salvage surgery, endoprosthetic reconstruction, and minimally invasive fixation techniques. His academic interests center on advancing the care of oncology patients by leading large, multicenter clinical trials designed to rigorously evaluate surgical and medical interventions. A key focus of his work is the validation and implementation of patient-reported outcome measures, ensuring that treatment effectiveness is assessed not only through clinical endpoints but also through the lived experiences of patients. In addition, he is dedicated to integrating digital health technologies into cancer care, using platforms such as mobile applications and wearable devices to enhance patient monitoring, facilitate real-time data collection, and promote personalized, patient-centered care. Collectively, these efforts aim to improve clinical outcomes, optimize quality of life, and inform evidence-based practices in musculoskeletal oncology.
Areas of Specialty and Research Interests
Bone and soft tissue sarcoma, metastatic bone disease, benign bone and soft tissue tumours
Focus on improving outcomes for oncology patients through large-scale clinical trials, validation of patient-reported outcome measures, and the integration of digital health technologies into cancer care.
